Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffiiBIOTECHNOLOGY AND BIOENGINEERINGIF3.62024-11-140OAAI
Minimal purification method enables developability assessment of recombinant proteinsBIOTECHNOLOGY AND BIOENGINEERINGIF3.62023-04-030OAAI
Steric accessibility of the N-terminus improves the titer and quality of recombinant proteins secreted from Komagataella phaffiiMICROBIAL CELL FACTORIESIF4.92022-09-054OA
RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC ChallengeMSPHEREIF3.12022-08-3110OAAI
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvantsHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52022-06-0616OAAI
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor-binding domain in engineered Komagataella phaffiiBIOTECHNOLOGY AND BIOENGINEERINGIF3.62021-11-1519OA
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in micePROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12021-09-0764OAAI
Properties of Compact Faint Radio Sources as a Function of Angular Size from StackingASTROPHYSICAL JOURNALIF5.42021-03-081OA